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Introduction
Apoptosis is an evolutionally conserved cell death pathway 
that regulates development and tissue homeostasis. Caspases, a 
family of cysteine proteases, play a critical role in mediating 
the execution of apoptosis. Although CED-3 is the sole cas-
pase required for programmed cell death in Caenorhabditis 
elegans, multiple caspases mediate apoptotic cell death in fl  ies 
and mammals. In these systems, the activation of upstream 
initiator caspases in response to proapoptotic signals leads to 
activation of the downstream executioner caspases. Although 
the core apoptotic pathway has been studied extensively, many 
aspects of the signaling networks that control the cellular de-
cision to undergo apoptosis remain unknown. Complex bio-
logical processes have been dissected successfully using 
genome-wide RNAi screens in Drosophila melanogaster cells. 
In this study, we describe the isolation of 10 genes, including 
the apical caspase Dronc, that are required for full caspase 
activation in response to DNA damage. Surprisingly, we dis-
covered that Charlatan (Chn), a regulator of neuronal cell 
differentiation (Tsuda et al., 2006), and ARD1, an N-acetyl-
transferase involved in cell fate specifi  cation (Whiteway and 
Szostak, 1985), regulate caspase activation. Importantly, we show 
that certain fl  y genes are functionally conserved as modifi  ers 
of caspase activation in the mammalian system. Our screen 
implicates Chn and ARD1 as a molecular link between cellular 
differentiation and apoptosis.
Results and discussion
To determine the feasibility of an RNAi approach in identifying 
apoptotic regulators, we tested whether the knockdown of Dcp-1, 
a downstream effector caspase functionally similar to mamma-
lian caspase-3, protects against DNA damage–induced apoptosis 
in Drosophila embryonic hemocyte Kc cells (Song et al., 2000). 
We used a topoisomerase II inhibitor, doxorubicin (dox), to in-
duce dose-dependent cell death (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200708090/DC1) that can be 
suppressed by z-VAD.fmk treatment (Fig. S1 B). As expected, 
dcp-1 RNAi partially protected cells from apoptosis induced by 
dox (Fig. S1 C), which is consistent with previous observa-
tions (Xu et al., 2006). We conclude that dox induces caspase-
dependent cell death in Kc cells that can be suppressed by a 
specifi  c double-stranded RNA (dsRNA) and, therefore, represents 
a suitable system for identifying modulators of apoptosis.
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poptosis is an evolutionally conserved cellular 
suicide mechanism that can be activated in re-
sponse to a variety of stressful stimuli. Increasing 
evidence suggests that apoptotic regulation relies on 
specialized cell death signaling pathways and also inte-
grates diverse signals from additional regulatory circuits, 
including those of cellular homeostasis. We present a 
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moval of Drosophila inhibitor of apoptosis 1. This set 
includes the Drosophila initiator caspase Dronc and, sur-
prisingly, several metabolic regulators, a candidate tumor 
suppressor, Charlatan, and an N-acetyltransferase, ARD1. 
Importantly, several of these genes show functional con-
servation in regulating apoptosis in mammalian cells. 
Our data suggest a previously unappreciated fundamental 
connection between various cellular processes and caspase-
dependent cell death.
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Figure 1. Identiﬁ  cation and conﬁ  rmation of dsRNAs that provide protection against DNA damage–induced apoptosis. (A) dsRNAs were screened in dupli-
cate plates for protection against dox treatment. The threshold for a hit was set at a z score of at least 2 for both plates (above blue dashed line). The plot 
represents the z score analysis of several plates that were enriched for the genes shown in Table I (red diamonds). (B) dsRNAs identiﬁ  ed in the primary 
screen were individually tested, and those that provided statistically signiﬁ  cant protection against dox in at least two inde  pendent experiments are shown 
(P < 0.05; t test). The graph represents a pool of 10 sample plates, and the error bars represent the SD of dsRNAs tested in triplicate. (C) This graph depicts 
the functional distribution of genes shown in B according to information provided by FlyBase (version FB2006_01).IDENTIFYING REGULATORS OF CASPASE ACTIVATION • YI ET AL. 621
A diverse set of dsRNAs protects ﬂ  y cells 
from dox-induced apoptosis
To identify dsRNAs that inhibit DNA damage–induced apopto-
sis in Kc cells, we performed a high-throughput screen using an 
established genome-wide Drosophila RNAi library that targets 
19,470 genes (Boutros et al., 2004). 81 dsRNAs resulted in a 
z score >2, which was the threshold for defi  ning a hit in our pri-
mary screen (Fig. 1 A). To eliminate dsRNAs that directly en-
hanced cellular ATP levels, the effect of dsRNAs on ATP levels 
was measured in the rescreen. We verifi  ed that 62 dsRNAs spe-
cifi  cally protected cells against dox-induced apoptosis (Fig. 1 B). 
To minimize off-target effects, we further examined any dsRNA 
with at least 19-nucleotide sequence identity with an off-target 
gene (Echeverri et al., 2006; Ma et al., 2006) by testing alterna-
tive dsRNAs distinct from the original targeting sequence 
for protection against cell death induced by dox treatment 
(Fig. S2 A, available at http://www.jcb.org/cgi/content/full/
jcb.200708090/DC1) and for caspase suppression induced by 
Drosophila inhibitor of apoptosis 1 (diap1) RNAi treatment as 
described in Fig. 3 (Fig. S2 B). Any dsRNA for a given gene 
failing to provide signifi  cant protection (P < 0.05) in either of 
these assays was eliminated, resulting in a fi  nal set of 47 genes 
(Fig. 1 B and Table S1).
The identifi  cation of three known regulators of cell death 
validates the ability of our screen to uncover genes required for 
promoting apoptosis. Silencing of Dronc provided maximal 
protection against dox treatment (Fig. 1 B), which is consistent 
with its role as the main checkpoint for apoptosis in the fl  y 
(Chew et al., 2004; Daish et al., 2004). In addition, knockdown 
of the ecdysone-induced protein Eip63F-1 provided the fourth 
strongest protection against DNA damage. The increased ex-
pression of Eip63F is detected in the premetamorphic salivary 
gland of Drosophila larvae, immediately before the ecdysone-
mediated induction of massive autophagic cell death (Gorski 
et al., 2003; Rusten et al., 2004). Lastly, our screen isolated Jra, 
the Drosophila orthologue of a known proapoptotic mammalian 
transcriptional factor, c-Jun, as a mediator of DNA damage–
induced apoptosis (Verheij et al., 1996).
Approximately 85% of the genes identifi  ed in the RNAi 
screen are characterized genes of known function or contain 
well-conserved functional domains, which regulate a wide range 
of cellular processes, including signaling, metabolism, and tran-
scription, whereas the remaining 15% of the genes have no known 
functional domains (Fig. 1 C). Altogether, our RNAi screen im-
plicates cell death genes (three), signaling molecules (13), met-
abolic regulators (10), metabolite transport factors (four), genes 
involved in ER/Golgi traffi  cking (four), chromatin/transcription 
regulators (two), RNA-processing factors (two), structural and cyto-
skeletal proteins (two), and genes of unknown function (seven) in 
mediating DNA damage–induced apoptosis (Table S1). Strikingly, 
20% of the genes are directly involved in cellular metabolic 
processes (Fig. 1 C), supporting an earlier proposal that the cel-
lular metabolic state critically infl  uences the threshold for in-
duction of apoptosis (Hammerman et al., 2004). To investigate 
where these genes operate in the apoptotic pathway, we con-
ducted specifi  c enzymatic and epistatic assays in fl  y and mam-
malian cells.
Identiﬁ  cation of genes involved in caspase-
dependent cell death
Next, we classifi  ed the genes that are specifi  cally involved in 
caspase-dependent cell death. We observed the substantial 
induction of caspase activity 8 h after dox treatment, preceding 
detectable cell death (Fig. S1, A and D). Any RNAi suppressing 
this activity implicates the target gene in early regulation of cas-
pase activation. In addition to dcp-1 RNAi, knockdown of dronc 
and jra signifi  cantly (P < 0.05) suppressed caspase-3/7–like 
activity in the presence of dox, whereas the negative control, 
RNAi against calpain A, a calcium-dependent cysteine prote-
ase, did not affect this pathway (Fig. 2 A). We expanded this 
analysis to all of the genes identifi  ed in the initial RNAi screen 
and discovered 20 dsRNAs that suppressed caspase activation 
induced by DNA damage (Table S1). Interestingly, as shown in 
Fig. 2 B, 12 of these genes were found to be epistatic to diap1, 
as discussed in the next section.
Figure 2. Classiﬁ  cation of genes that function upstream of the executioner 
caspases. (A) Kc cells were transfected with dsRNAs as indicated and 
treated with dox to induce caspase activation. This graph is representative 
of three independent experiments. RLU, relative light unit. (B) dsRNAs were 
tested for the suppression of caspase activity induced by dox treatment. 
Selected dsRNAs that provided statistically signiﬁ  cant inhibition of caspase 
activity in at least two independent experiments are shown (*, P < 0.05; 
t test). This graph shows a pool of six sample plates. The error bars represent 
the SD of dsRNAs tested in triplicate.JCB • VOLUME 179 • NUMBER 4 • 2007  622
Identiﬁ  cation of genes epistatic to DIAP1
Next, we performed diap1 epistatic analysis to further catego-
rize the genes. DIAP1, the fly orthologue of the mammalian 
inhibitors of apoptosis proteins, is a direct inhibitor of caspases, 
and defi  ciency in DIAP1 leads to rapid caspase activation and 
apoptosis in vivo (Wang et al., 1999). Thus, apoptosis induced 
by the loss of DIAP1 presents an alternative apoptotic assay in-
dependent of DNA damage. Silencing of genes that regulate acti-
vation of the core apoptotic machinery may provide protection 
against apoptosis induced by both DNA damage and the loss of 
DIAP1. RNAi against dcp-1 partially suppressed cell death induced 
by the depletion of DIAP1 in Kc cells (Fig. 3 A). Also, dronc RNAi 
potently protected cells against apoptosis induced by defi  ciency 
in DIAP1 as reported previously (Meier et al., 2000; Chai et al., 
2003). Altogether, 32 of the genes confi  rmed from our primary 
screen provided signifi  cant (P < 0.05) protection against cell 
death induced by the silencing of DIAP1 (Table S1 and Fig. 3 B).
Interestingly, 12 dsRNAs suppressed caspase-3/7–like 
activity after dox treatment and protected against cell death 
induced by diap1 RNAi, suggesting that these genes are required 
for apoptosis induced by multiple stimuli (Table I). To confi  rm 
that these genes are necessary for the full activation of caspases, we 
determined whether these dsRNAs could suppress spontaneous 
caspase activity induced by diap1 RNAi. We observed maximal 
induction of caspase activity by diap1 RNAi after 24 h, and this 
effect was completely suppressed by dsRNA against dcp-1 
(Fig. S1 E). Importantly, ablating 10/12 dsRNAs resulted in the 
signifi  cant (P < 0.05) suppression of caspase activity compared 
with diap1 RNAi only (Fig. 3 C).
In addition to dronc RNAi, dsRNAs targeting chn and 
dARD1 provided the strongest suppression of spontaneous cas-
pase activity. Consistent with our observation that RNAi against 
chn protects against DNA damage–induced cell death, the mam-
malian orthologue neuron-restrictive silencer factor (NRSF)/
RE1-silencing transcription factor (REST) was recently identi-
fi  ed as a candidate tumor suppressor in epithelial cells (Westbrook 
et al., 2005). Previous work indicates that Chn and NRSF/REST 
function as a transcriptional repressor of neuronal-specifi  c genes 
Figure 3.  A set of genes epistatic to Diap1 and criti-
cal for caspase activation. (A) Kc cells were transfected 
with dsRNAs as indicated followed by transfection 
with RNAi against diap1. This graph is representative 
of three independent experiments. (B) dsRNAs were 
tested for protection against cell death induced by the 
loss of Diap1. Selected dsRNAs that provided statisti-
cally signiﬁ  cant protection against diap1 RNAi in at 
least two independent experiments are shown. This graph 
represents a pool of three sample plates. (C) dsRNAs 
were tested for suppression of caspase activation in-
duced by the loss of Diap1. Note that 10/12 dsRNAs 
showed statistically signiﬁ  cant suppression of caspase 
activation compared with RNAi against diap1 only. 
This graph is representative of three independent ex-
periments. The error bars represent the SD of dsRNAs 
tested in triplicate. *, P < 0.05; t test.IDENTIFYING REGULATORS OF CASPASE ACTIVATION • YI ET AL. 623
(Chong et al., 1995; Schoenherr and Anderson, 1995; Tsuda 
et al., 2006), suggesting that cellular differentiation may render 
cells refractory to caspase activation and apoptosis. Also, we 
identifi  ed several metabolic genes, CG31674, CG14740, and 
CG12170, that may be involved in the general regulation of cas-
pase activation. Recently, Nutt et al. (2005) demonstrated that 
NADPH produced by the pentose phosphate pathway regulates 
the activation of caspase-2 in nutrient-deprived Xenopus laevis 
oocytes. Together with our results, these observations provide 
further evidence for an intimate link between the regulation of 
metabolism and induction of apoptosis.
Evolutionary conservation of the novel 
regulators of apoptosis
To further explore the signifi  cance of our fi  ndings, we examined 
whether silencing the mammalian orthologues of the fl  y genes 
identifi  ed from the RNAi screen confers protection against dox-
induced cell death in mammalian cells. We selected a set of mam-
malian orthologues that are believed to be nonredundant. The list 
includes the orthologues of dMiro, which functions as a Rho-like 
GTPase; dARD1, which functions as an N-acetyltransferase; 
CG12170, which functions as a fatty acid synthase; and Chn, which 
functions as a transcriptional repressor (RHOT1, hARD1, OXSM, 
and REST, respectively; FlyBase). In addition, we tested Plk3, 
a mammalian orthologue of Polo, as dsRNA targeting polo 
potently protected against dox treatment (Fig. 1).
We assessed the ability of siRNAs targeting a gene of 
interest to protect against DNA damage in HeLa cells. As a posi-
tive control, cells were transfected with siRNAs targeting Bax 
or Bak, two central regulators of mammalian cell death (Wei 
et al., 2001; Zong et al., 2001). Indeed, silencing of Bax or Bak 
resulted in significant protection (P < 0.05) against dox-
induced cell death (Fig. 4 A). We observed that plk3 RNAi pro-
vided partial protection against dox treatment, which is consistent 
with previous studies implicating Plk3 in stress-induced apop-
tosis (Xie et al., 2001a,b; Bahassi et al., 2002). Interestingly, 
the knockdown of hARD1 dramatically enhanced cell survival 
in the presence of dox to levels similar to that of Bak. This pro-
tective effect was also evident at the morphological level. 
In cells transfected with a nontargeting control siRNA, dox treat-
ment resulted in typical apoptotic morphology, including cell 
rounding and membrane blebbing (Fig. 4 B). In direct contrast, 
cells transfected with siRNAs against hARD1 maintained a 
normal and healthy morphology and continued to proliferate in 
the presence of dox.
To examine whether the protection provided by siRNAs 
targeting hARD1 and plk3 is associated with the suppression of 
caspase activation, we measured caspase activity in these cells 
treated with dox. RNAi against plk3 provided partial suppres-
sion of caspase activity, again supporting the protection pheno-
type observed in Fig. 4 A. Interestingly, the depletion of REST 
resulted in some suppression of caspase activity in the presence 
of dox even though the protection against cell death was not 
statistically signifi  cant (Fig. 4 C). Consistent with our viability 
assay, complete suppression of caspase-3/7 activity was observed 
in cells transfected with hARD1 siRNA (Fig. 4 C). These results 
indicate that hARD1 is required for caspase-dependent cell 
death induced by DNA damage. Furthermore, we observed that 
all four siRNAs targeting hARD1 were individually capable of 
providing robust protection against cell death, strongly suggest-
ing that these siRNAs target hARD1 specifi  cally (Fig. 4 D).
Because the silencing of hARD1 dramatically suppressed 
activation of the downstream caspases, we examined whether 
activation of the upstream caspases in response to dox treatment 
is also perturbed. Remarkably, hARD1 RNAi inhibited the cleav-
age of caspase-2 and -9 in cells treated with dox, whereas cas-
pase cleavage was readily detected in control cells  (Fig. 4 E). 
Thus, we propose that hARD1 regulates the signal transduction 
pathway apical to the apoptotic machinery in the DNA damage 
response itself or the activation of upstream caspases.
Consistent with the results of the caspase-3/7 assay (Fig. 4 C), 
silencing of hARD1 completely inhibited the appearance of 
activated caspase-3 induced by dox (Fig. 4 E). We used this 
assay for a hARD1 complementation experiment to demonstrate 
the proapoptotic role of hARD1 in response to DNA damage. 
We used a new siRNA pool targeting the 5′ untranslated region 
of hARD1 (5′si), which inhibited caspase-3 cleavage induced 
by dox treatment (Fig. 4 F). Furthermore, we observed caspase-3 
Table I. A summary of the genes identiﬁ  ed in the RNAi screen that modulate caspase activation
Gene ID Gene name Known mammalian 
orthologue
Gene ontology Functional class
CG8090 Dronc (Nc) Caspase Apical caspase Cell death
CG5410 dMiro Miro Mitochondrial GTPase Signaling
CG11989 dARD1 hARD1 Protein acetyltransferase Signaling
CG14740 NA Cs Citrate synthase Metabolism
CG31674 NA GRHPR Glyoxylate reductase Metabolism
CG12170 NA OXSM Fatty acid biosynthesis Metabolism
CG10725 NA NA Polysaccharide metabolism Metabolism
CG9258 nrv1 Atp1b1 Na
+/K
+ATPase Transporters
CG8029 NA NA Proton-coupled ATP synthase Transporters
CG7438 myo31DF Myo1D Type 1 myosin Transporters
CG11798 Charlatan (chn) NRSF/REST Transcriptional repressor Transcription
CG6712 NA RPF1 Ribosomal RNA processing RNA processing
NA, not applicable.JCB • VOLUME 179 • NUMBER 4 • 2007  624
Figure 4.  hARD1 is required for caspase activation in response to DNA damage in mammalian cells. (A) HeLa cells were transfected with a pool of four 
siRNAs as indicated followed by treatment with 1.25 μg/ml dox for 20 h. This graph is representative of three independent experiments. (B) HeLa cells 
were transfected with siRNAs as indicated and treated with 1.25 μg/ml dox followed by a 12-h incubation. Cells were visualized by bright-ﬁ  eld micros-
copy, and representative images of samples tested in triplicate are shown. (C) HeLa cells were transfected with siRNAs as indicated and were treated with 
5 μg/ml dox for 8 h. This graph is representative of three independent experiments. (D) HeLa cells were transfected with a pool of siRNAs or individual 
siRNAs targeting hARD1 as indicated and were treated with 1.25 μg/ml dox for 20 h. This graph is representative of three independent experiments. 
(E) HeLa cells were transfected with siRNAs as indicated and treated with 5 μg/ml dox for 8 h. Note that RNAi against hARD1 completely inhibited the cleav-
age of caspase-2, caspase-9, and caspase-3 compared with nontargeting siRNA (arrows). This experiment is representative of two independent experiments. 
(F) HeLa cells were transfected with siRNAs as indicated and treated with 5 μg/ml dox for 8 h. Asterisks represent nonspeciﬁ  c bands recognized by the 
indicated antibody. This experiment is representative of two independent experiments. (A, C, and D) *, P < 0.05; t test. Error bars represent SD.IDENTIFYING REGULATORS OF CASPASE ACTIVATION • YI ET AL. 625
cleavage in reconstituted hARD1 knockdown cells. Because 
six out of six siRNAs against hARD1 provided strong protection 
against DNA damage–induced apoptosis and complementation 
of hARD1-sensitized cells to caspase activation, we conclude 
that the functional role of ARD1 for dox-induced apoptosis is 
evolutionally conserved from Drosophila to mammals.
In contrast to our results, Arnesen et al. (2006) reported that 
hARD1 is necessary to maintain cell survival. One possible ex-
planation for this discrepancy can be attributed to the inherent dif-
ferences between the siRNAs used in this study and that used by 
Arnesen et al. We observed that two out of two siRNAs used in 
the Arnesen et al. (2006) study resulted in a decrease in cell sur-
vival in the absence of stress signal, whereas none of the siRNAs 
tested as such had a negative effect on cell survival (Fig. S2 D).
In summary, we used an unbiased RNAi screening platform 
in Drosophila cells to identify genes involved in promoting DNA 
damage–induced apoptosis. We isolated 47 dsRNAs that sup-
press cell death induced by dox. These genes encode for known 
apoptotic regulators such as Dronc, the Drosophila orthologue of 
the known proapoptotic transcriptional factor c-Jun, and an ecdy-
sone-regulated protein, Eip63F-1, thereby validating our primary 
screen. Furthermore, our study implicates a large class of metabolic 
genes that were previously not suspected to have a role in modu-
lating caspase activation and apoptosis, such as genes involved 
in fatty acid biosynthesis (CG11798), amino acid/carbohydrate 
 metabolism (CG31674), citrate metabolism (CG14740), complex 
carbohydrate metabolism (CG10725), and ribosome biosynthesis 
(CG6712). These results support an earlier proposal (Hammerman 
et al., 2004; Nutt et al., 2005) that the cellular metabolic status 
regulates the threshold for activation of apoptosis and thus plays 
a critical role in the decision of a cell to live or die.
Of particular interest is the identifi  cation of ARD1. We pre-
sent evidence that RNAi against ARD1 provides protection 
against cell death and leads to the suppression of caspase acti vation 
induced by DNA damage in fl  y cells and HeLa cells. Furthermore, 
defi  ciency in dARD1 renders fl  y cells resistant to the spontane-
ous caspase activity and cell death associated with loss of Diap1. 
Importantly, we provide substantial evidence that hARD1 is re-
quired for caspase activation in the presence of DNA damage in 
mammalian cells. Cleavage of initiator and executioner caspases 
are suppressed in hARD1 RNAi cells treated with dox, suggesting 
that hARD1 functions further upstream of caspase activation, 
and the complementation of hARD1 knockdown cells restores 
caspase-3 cleavage. These data indicate that ARD1 is necessary 
for DNA damage–induced apoptosis in fl  ies and mammals.
ARD1 functions in a complex with N-acetyltransferase to 
catalyze the acetylation of the N
α-terminal residue of newly 
synthesized polypeptides and has been implicated in the regula-
tion of heterochromatin, DNA repair, and the maintenance of 
genomic stability in yeast (Mullen et al., 1989; Aparicio et al., 
1991; Ouspenski et al., 1999; Wilson, 2002; Bilton et al., 2006). 
These studies suggest that ARD1 may be involved in regulating 
an early step in response to DNA damage. We anticipate that 
future studies will focus on determining whether ARD1 func-
tions in similar processes in mammals. The diversity of genes 
identifi  ed in our screen illustrates the complex cellular integra-
tion of survival and death signals through multiple pathways.
Materials and methods
Tissue culture
Drosophila Kc167 cells were maintained in Schneider’s Drosophila medium 
with 10% FBS in the presence of penicillin and streptomycin (Invitrogen). 
HeLa cells were maintained in DME with 10% newborn calf serum in the 
presence of penicillin and streptomycin (Invitrogen) and were passaged for 
no more than 6 wk.
RNAi screening
Drosophila Kc cells (10
5/well in 384-well plates) were transfected with 
prealiquoted dsRNAs (0.5 μg/well) followed by a 48-h incubation to al-
low for protein turnover. Subsequently, cells were treated with 5 μg/ml dox 
(Sigma-Aldrich) for an additional 48-h incubation. Cell viability was deter-
mined by measuring cellular ATP levels (CellTiter-Glo luminescent cell via-
bility assay; Promega). Positive hits for this screen were deﬁ  ned as dsRNAs 
that increased cellular ATP levels by at least two units of SD above the 
mean level of the plate, a z score of two, in duplicate.
Rescreen
Conﬁ  rmation of these hits was performed using newly synthesized dsRNAs. 
cDNA was ampliﬁ  ed from ﬂ  y genomic DNA using primers optimally de-
signed for RNAi (sequences provided by N. Ramadan, Drosophila RNAi 
Screening Center, Harvard Medical School, Boston, MA). dsRNA synthesis 
was conducted according to the manufacturer’s recommended protocol 
(MEGAscript; Ambion). Kc cells (2 × 10
5/well in 96-well plates) were 
transfected with dsRNAs (1 μg/well) followed by treatment with dox. Each 
dsRNA was tested in triplicate and in at least two independent experiments. 
Cell viability was determined as a ratio between ATP levels of cells treated 
with a given dsRNA in the presence of dox and control cells treated with 
the dsRNA only. Statistically signiﬁ  cant protection (P < 0.05) against dox-
induced cell death was determined by comparing the cell viability of cells 
treated with RNAi in the presence of dox with the cell viability of cells 
treated with dox alone. Fold protection against dox was determined as the 
ratio between the mean cell viability of cells transfected with dsRNA in the 
presence of dox and cells treated with only dox.
Caspase activation assay
Kc cells were transfected in 96-well plates with the 62 dsRNAs that were 
conﬁ  rmed in the primary screen followed by treatment with dox for 8 h to 
induce caspase activation. Each dsRNA was tested in triplicate and in at 
least two independent experiments. Caspase-3/7–like activity was quanti-
ﬁ  ed using a luciferin-labeled DEVD peptide substrate (Caspase-Glo 3/7 
assay; Promega). Fold caspase-3/7–like activity was determined as the 
ratio between the mean caspase-3/7–like activity of cells transfected with 
dsRNA in the presence of dox and cells treated with dox only.
DIAP1 epistasis studies
Kc cells were transfected in 96-well plates with individual dsRNAs target-
ing the 62 genes conﬁ  rmed in the initial screen. After a 24-h incubation, 
these cells were transfected with 1 μg diap1 dsRNA for an additional 48-h 
incubation when cell viability was quantiﬁ  ed (as described in the Rescreen 
section). Fold protection against diap1 RNAi was determined as the ratio 
between the mean cell viability of cells transfected with the indicated 
dsRNA and diap1 RNAi and the mean cell viability of cells transfected with 
diap1 RNAi only. For the caspase activation assay, Kc cells were trans-
fected with dsRNA as indicated followed by transfection with dsRNA 
against diap1 and an additional 24-h incubation.
Mammalian RNAi studies
Low-passage HeLa cells were transiently transfected (5 × 10
5/well in 
96-well plates) with a pool of four siRNAs unless otherwise indicated (50 nM; 
predesigned ON-TARGETplus siRNAs; Dharmacon) using HiPerFect trans-
fection reagent (QIAGEN). After a 48-h incubation, cells were treated with 
dox (concentrations and incubation times are noted in ﬁ  gures).  siRNAs 
were tested in triplicate for each independent experiment. Cell viability and 
caspase-3/7 activity was quantiﬁ  ed as described for KC cells. Images were 
obtained using bright-ﬁ  eld microscopy.
For detection of caspase cleavage, HeLa cells were transfected with 
siRNAs (1.5 × 10
5/well in six-well plates) followed by treatment with dox. 
Cells were lysed directly in SDS sample buffer and subjected to SDS-PAGE 
analysis. Caspases were detected by immunoblotting using the following 
antibodies: caspase-9 (R&D Systems), caspase-2 (Alexis), caspase-3 (Cell 
Signaling Technology), and cleaved caspase-3 (Cell Signaling Technology). 
hARD1 was detected using a rabbit polyclonal antibody (provided by JCB • VOLUME 179 • NUMBER 4 • 2007  626
M.C. Brahimi-Horn, University of Nice, Centre National de la Recherche 
Scientiﬁ  que, Nice, France).
For hARD1 reconstitution experiments, HeLa cells were transfected 
with a pool of two siRNAs targeting the 5′ untranslated region of hARD1 
(sequences C  U  G  A  C  U  G  C  G  C  C  U  U  C  A  C  G  A  U  U  U   and G  C  U  G  A  C  U  G  C  G  C  C  -
U  U  C  A  C  G  A  U  U  ; Dharmacon) in six-well plates followed by a 24-h incuba-
tion. This was followed by transient transfection of C-terminal–tagged 
hARD1-myc/his using TransIT-LT1 transfection reagent (Mirus) and an addi-
tional 24-h incubation. After dox treatment, cells were lysed and analyzed 
by Western blotting.
Microscopy
Images of HeLa cells were obtained using a microscope (Eclipse TE300; 
Nikon) with a 10× Ph L objective lens and a camera (ORCA-ER; Hamamatsu) 
at room temperature. Openlab 3.1.7 acquisition software (Improvision) was 
used to analyze the images.
Online supplemental material
Fig. S1 shows a characterization of dox-induced cell death and controls for 
RNAi screen. Fig. S2 presents semiquantitative analysis of dsRNAs to vali-
date the RNAi library. Table S1 provides a comprehensive list of genes 
identiﬁ  ed in the primary screen. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200708090/DC1.
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